08 March 2018
Within the framework of the Alternating Meetings of the Prime Minister of Québec and the Prime Minister of France, Rémi Quirion, Québec Chief Scientist, met with Olivier Exertier, Secretary-General of CLARA, and Véronique Trillet-Lenoir, Chair of the CLARA Management Committee, at the Hôtel de Matignon, in Paris, on March 8, 2018.
At that meeting, an agreement was signed between CLARA and the Québec Oncopole, bringing together key players in cancer research, including Université de Montréal, McGill University, Université de Sherbrooke, Université Laval, Université de Lyon, Université Saint-Etienne, Université Grenoble and Université Clermont-Ferrand. By establishing a formal collaboration between the two centers of excellence, the partnership will promote cross-fertilization with respect to common themes of interest such as genomics and precision medicine, cell therapy and the organization of cancer care. The announcement builds on productive scientific collaborations connecting CLARA and Canada since 2000, involving over 1,300 publications.
Véronique Trillet-Lenoir is delighted by this “joint mobilization that will foster exchanges between the two regions and contribute to the attractiveness of cancer research”.
The implementation of joint research programs and the mutual investment in student mobility scholarships will shape this international collaboration. Focusing on knowledge sharing between both parties, the partnership will also foster the organization of scientific symposiums bringing together experts from the Auvergne-Rhône-Alpes region and Québec. A first event is scheduled for November of 2018 as part of the entretiens Jacques Cartier, to be held in Auvergne-Rhône-Alpes.
Rémi Quirion said that he is pleased to see that a collaboration has taken shape, which he expects to be “a source of mutual enrichment that will provide international outreach through common research projects and the exchange of good practices”.
Oncopole is a Quebec hub for research, development and investment to accelerate the fight against cancer. Created in February of 2017, it is the product of a unique co-creation process led by the Fonds de recherche du Québec – Santé (FRQS) and made possible by an initial $15M investment from Merck Canada. Oncopole’s mission is to act as a catalyst leveraging actions made by the key players in Quebec’s oncology and innovation research ecosystem. As a result, it aims to position the province as a leader in the field. Its priorities of action, namely research, entrepreneurship, commercialization and integration of innovation, as well as clinical relevance, are orchestrated in order to foster the mobilization of stakeholders, the discovery of innovative approaches to fight cancer and, ultimately, a positive impact for the benefit of patients. For more information, go to: oncopole.ca
About the Lyon Auvergne Rhône-Alpes Cancer Cluster (CLARA)
The Lyon Auvergne Rhône-Alpes Cancer Cluster (CLARA) is an initiative launched and funded by the public authorities (National Cancer Institute, Local Authorities and the European Regional Development Fund). It is part of the National Cancer Plans and aims to develop oncology research in Auvergne-Rhône-Alpes. Since 2003, CLARA has been bringing together academic, clinical and industrial players throughout the region, in the service of a regional, national and international strategy for the fight against cancer with a twofold objective: the rapid transfer of discoveries to patients and the economic valuation of research. In addition to its commitment to all research stakeholders to promote their decompartmentalization and collaborations, the cancer cluster supports projects through a structured service offer developed in line with their needs. CLARA is also developing actions to open research to the humanities and social sciences and public health issues, putting the patient at the heart of research.